LA JOLLA, Calif., March 22 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at the Future Leaders in the Biotech Industry Conference in New York on Thursday, March 29th at 9:00 a.m., eastern.
A webcast of Dr. Kurtz’s presentation will be available live. You can access the webcast at: www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.
About TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics is a clinical stage biopharmaceutical company that discovers and develops small molecule drugs to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, including cognitive impairment associated with schizophrenia and Alzheimer’s disease. TorreyPines’ common stock is traded on The NASDAQ Global Stock Market under the symbol “TPTX.” For detailed company information, including copies of this and other press releases, please visit TorreyPines’ website at www.torreypinestherapeutics.com.
This press release contains forward-looking statements or predictions. Such statements are subject to numerous known and unknown risks, uncertainties and other factors, which may cause TorreyPines’ actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These and other risks which may cause results to differ are described in greater detail in TorreyPines’ registration statement on Form S-4, as amended, as filed with the Securities and Exchange Commission, the “Risk Factors” section of TorreyPines’ Form 10-Q for the quarter ended September 30, 2006 and TorreyPines’ other filings with the Securities and Exchange Commission. The forward-looking statements are based on current information that is likely to change and speak only as of the date hereof.
TorreyPines Therapeutics, Inc.
CONTACT: Craig Johnson of TorreyPines Therapeutics, Inc., +1-858-623-5665,ext. 158, cjohnson@torreypinestherapeutics.com; or Media, PatriciaGarrison, +1-917-322-2567, pgarrison@RxIR.com, or Investors, Rhonda Chiger,+1-917-322-2569, rchiger@RxIR.com, both of Rx Communications, forTorreyPines Therapeutics, Inc.
Web site: http://www.torreypinestherapeutics.com/
